Form 4: Twist Bioscience Exec Sells Shares for Tax Obligations

Twist Bioscience's Senior VP, Chief Legal Officer & Corporate Secretary, Dennis Cho, sold 124 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp, sold 124 shares of common stock.
• The transaction occurred on October 2, 2025, at a price of $29.161 per share.
• The sale was non-discretionary, mandated by the company's equity incentive plan to cover tax withholding obligations from vested Restricted Stock Units.
• Following the transaction, Dennis Cho beneficially owns 102,586 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which is a common occurrence for executives with vested equity awards and does not indicate a change in management's view of the company's prospects.

Future Outlook

NA

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This is a routine insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not reflect broader industry trends.

Stakeholder Impact

• Shareholders: Minimal impact as it's a routine, non-discretionary sale for tax purposes, not a signal of lack of confidence.
• Employees: No direct impact.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary "sell to cover" transaction by an executive to satisfy tax obligations upon RSU vesting. Such transactions are common and do not typically signal a change in the company's fundamentals or management's outlook. Therefore, it provides no new information to warrant a change from a current "hold" position.

Keywords

Twist Bioscience, TWST, Dennis Cho, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Equity Incentive Plan